Новости EN

Expert: non-invasive prenatal testing increases the accuracy of detecting aneuplody to 100%


In several countries, NIPT (non-invasive prenatal test) is used as a first-line test for all pregnant women, which allows to bring the accuracy of detection of frequent aneuploidy to almost 100%, says Elena Baranova, Ph.D., medical director of the company EVOGEN, at the IV All-Russian seminar "Reproductive Potential of Russia: Versions and Contraverses".

NIPT (non-invasive prenatal test) is based on the analysis of fetal extracellular DNA in maternal blood by high-throughput sequencing ("NGS"). NIPT is non-invasive for the fetus, does not bear the risk of losing it, has high accuracy, which reduces the risk group and the need to use invasive procedures.

- In several countries, for example, in Belgium, the Netherlands, China, NIPT is a routine screening that is used as a first-line test for all pregnant women. The accuracy of detection of frequent aneuploidy using NIPT increases to almost 100%. There is also a strategy in which NIPT is used for cohort screening of medium risk - in such cases, a risk threshold of 1: 1000 or 1: 2500 is used, said Elena Baranova.

EVOGEN is an innovative laboratory offering NIPT with full localization of technology in Russian Federation.


Sign up for our newsletter to stay updated on the news in the world of genetics
Your email
Thanks for subscribing!